Raltegravir (Isentress, Merck) receives FDA approval for HIV treatment.
Accelerated approval for Merck's raltegravir (
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.